Max Jaderberg's banner

Max Jaderberg

@maxjaderberg • 19,685 subscribers

President @IsomorphicLabs: solving disease with AI. Prev: Deepmind, Vision Factory (acq. Google), Oxford VGG.

Shorts

We've been defining the actual frontier of AI for science: - created the most powerful agents and generative models of our biomolecular world - coupled with the most accurate models of state - proved again and again ability to break novel ground in drug design >>> now I'm looking for those who want to push frontier LLMs even further, in an environment where you see the impact on real science the next day 1/2

We've been defining the actual frontier of AI for science: - created the most powerful agents and generative models of our biomolecular world - coupled with the most accurate models of state - proved again and again ability to break novel ground in drug design >>> now I'm looking for those who want to push frontier LLMs even further, in an environment where you see the impact on real science the next day 1/2

10,711 views

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

Excited to show a glimpse of the next generation of AlphaFold from our teams at Isomorphic Labs and Google DeepMind. This model expands beyond proteins to include other molecules like small molecules and nucleic acids, and improves accuracy on proteins 1/n

Excited to show a glimpse of the next generation of AlphaFold from our teams at Isomorphic Labs and Google DeepMind. This model expands beyond proteins to include other molecules like small molecules and nucleic acids, and improves accuracy on proteins 1/n

117,436 views • 2 years ago

We’ve been developing AlphaFold 3 to advance how we do drug design at Isomorphic Labs. This model allows us to a) do rational structure based drug design in-silico, and b) understand more about the biological context of targets 1/

We’ve been developing AlphaFold 3 to advance how we do drug design at Isomorphic Labs. This model allows us to a) do rational structure based drug design in-silico, and b) understand more about the biological context of targets 1/

25,772 views • 2 years ago

No more content to load